MyFinsight
Home
About
Contact
nby: the income statement
Download
Download image
Net (loss) income
attributable to common...
-$1,293K
(41.68%↑ Y/Y)
Net (loss) income
-$1,293K
(-6.68%↓ Y/Y)
Net income from
discontinued operations, net...
$40K
Net loss from
continuing operations
-$1,333K
(-9.98%↓ Y/Y)
Product revenue, net
$521K
(-78.66%↓ Y/Y)
Other expense, net
-$77K
Operating loss
-$1,256K
(-18.38%↓ Y/Y)
Gross profit
$42K
(-97.36%↓ Y/Y)
Cost of goods sold
$479K
(-43.51%↓ Y/Y)
Total operating
expenses
$1,298K
(-51.09%↓ Y/Y)
Impairment of long-lived
assets
$87K
General and
administrative
$1,211K
(-28.89%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
NovaBay Pharmaceuticals, Inc. (NBY)
NovaBay Pharmaceuticals, Inc. (NBY)